Semaglutide, a synthetic analog of glucagon-like peptide-1 (GLP-1), has garnered attention for its intriguing properties and potential implications in various r ...

Semaglutide: A Peptide with Broader Implications Semaglutide, a glucagon-like peptide-1 (GLP-1) analog, is another peptide with potential research implications beyond its primary metabolic targets.

Some of the most common peptides for weight loss are glucagon-like peptide 1 (GLP-1) receptor agonists. They include semaglutide (Wegovy), liraglutide (Saxenda), and tirzepatide (Zepbound).

Challenges with glucagon-like peptide-1 (GLP-1) agonist initiation: a case series of semaglutide overdose administration errors. Clinical Toxicology . Published online March 12, 2024. doi: 10.1080 ...

Semaglutide is the active ingredient in drugs such as Wegovy and Ozempic. “Glucagon-like peptide-1 agonist (GLP-1) drugs [that contain semaglutide] have transformed type 2 diabetes care, ...

PeptiDream, the Japanese biopharma with a penchant for deal-making, has a new bargaining chip in its hand in the red-hot obesity space. The firm’s oral macrocyclic peptides preserved lean muscle ...

With Semaglutide, postmenopausal women ... Glucagon-like peptide-1 ... Metabolic syndrome, insulin resistance and menopause: the changes in body structure and the therapeutic approach. GREM. doi ...